Mangrove Partners IM LLC Buys Shares of 1,828 Axon Enterprise, Inc $AXON

Mangrove Partners IM LLC bought a new stake in Axon Enterprise, Inc (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,828 shares of the biotechnology company’s stock, valued at approximately $1,038,000.

Several other large investors have also recently bought and sold shares of AXON. Creative Financial Designs Inc. ADV bought a new position in Axon Enterprise in the fourth quarter valued at approximately $28,000. New Millennium Group LLC bought a new position in Axon Enterprise in the third quarter valued at approximately $29,000. Sound Income Strategies LLC lifted its stake in Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after buying an additional 44 shares in the last quarter. Camelot Portfolios LLC bought a new position in Axon Enterprise in the fourth quarter valued at approximately $30,000. Finally, AlphaCentric Advisors LLC bought a new position in Axon Enterprise in the fourth quarter valued at approximately $34,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $435.39 on Wednesday. The company’s fifty day simple moving average is $411.40 and its 200-day simple moving average is $487.65. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The firm has a market cap of $35.09 billion, a PE ratio of 174.86, a P/E/G ratio of 8.06 and a beta of 1.45. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The business had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.47 earnings per share. Equities research analysts expect that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CRO Cameron Brooks sold 1,242 shares of the business’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the sale, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. The trade was a 2.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 20,000 shares of the business’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $10,000,000.00. Following the completion of the sale, the chief executive officer directly owned 3,060,997 shares in the company, valued at approximately $1,530,498,500. This represents a 0.65% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 38,989 shares of company stock valued at $19,090,083 over the last 90 days. 4.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on AXON. Barclays cut their price target on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research note on Friday, May 8th. Citizens Jmp cut their price target on shares of Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating on the stock in a research note on Thursday, May 7th. Wall Street Zen raised shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. Morgan Stanley set a $600.00 price target on shares of Axon Enterprise in a research note on Thursday, May 7th. Finally, Robert W. Baird set a $800.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $712.75.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.